Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2811 USD | +4.11% | -5.80% | -88.09% |
May. 09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.09% | 17.4M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- Transcript : GlycoMimetics, Inc., Q2 2021 Earnings Call, Aug 05, 2021